Isla P Garraway

Title(s)Professor, Urology
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Mechanisms of Prostate Cancer Metastasis
    NIH R01CA271750Sep 17, 2021 - Aug 31, 2026
    Role: Co-Principal Investigator
    B ELEMENT IN TATA LESS PROMOTERS
    NIH F31HG000117Apr 1, 1994
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer. Eur Urol. 2024 Mar 14. Nickols NG, Tsai S, Kane N, Tran S, Ghayouri L, Diaz-Perez S, Thein M, Anderson-Berman N, Eason J, Kishan AU, Steinberg ML, Reiter RE, Lee SP, Gin GE, Kwon R, Chang MG, Chao HH, Solanki AA, Sexton R, Lewis M, Lorentz W, Cheung MK, Gage DL, Duriseti S, Valle L, Berenji G, Aronson WJ, Garraway IP, Rettig MB. PMID: 38490853.
      View in: PubMed   Mentions:    Fields:    
    2. Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care Systems. JAMA Netw Open. 2024 Mar 04; 7(3):e242852. Wadhwa A, Roscoe C, Duran EA, Kwan L, Haroldsen CL, Shelton JB, Cullen J, Knudsen BS, Rettig MB, Pyarajan S, Nickols NG, Maxwell KN, Yamoah K, Rose BS, Rebbeck TR, Iyer HS, Garraway IP. PMID: 38502125; PMCID: PMC10951732.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer. JAMA Netw Open. 2023 Dec 01; 6(12):e2345906. Ma TM, Agarwal N, Mahal B, Barragan-Carrillo R, Spratt D, Rettig MB, Valle LF, Steinberg ML, Garraway I, Vapiwala N, Xiang M, Kishan AU. PMID: 38039002; PMCID: PMC10692845.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Association between prediagnostic prostate-specific antigen and prostate cancer probability in Black and non-Hispanic White men. Cancer. 2024 01; 130(2):224-231. Lee KM, Bryant AK, Lynch JA, Robison B, Alba PR, Agiri FY, Pridgen KM, DuVall SL, Yamoah K, Garraway IP, Rose BS. PMID: 37927109.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    5. In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer". Oncologist. 2023 Nov 02; 28(11):e1129-e1130. Valle LF, Nickols NG, Yamoah K, Garraway IP, Maxwell KN, Lynch JA. PMID: 37706534; PMCID: PMC10628590.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer. bioRxiv. 2023 Oct 12. Qian C, Yang Q, Rotinen M, Huang R, Kim H, Gallent B, Yan Y, Cadaneanu RM, Zhang B, Kaochar S, Freedland SJ, Posadas EM, Ellis L, Vizio DD, Morrissey C, Nelson PS, Brady L, Murali R, Campbell MJ, Yang W, Knudsen BS, Mostaghel EA, Ye H, Garraway IP, You S, Freeman MR. PMID: 37905039; PMCID: PMC10614109.
      View in: PubMed   Mentions:
    7. Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans. Oncologist. 2023 06 02; 28(6):e473-e477. Valle LF, Nickols NG, Hausler R, Alba PR, Anglin-Foote T, Perez C, Yamoah K, Rose BS, Kelley MJ, DuVall SL, Garraway IP, Maxwell KN, Lynch JA. PMID: 37084789; PMCID: PMC10243786.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023. J Natl Compr Canc Netw. 2023 03; 21(3):236-246. Moses KA, Sprenkle PC, Bahler C, Box G, Carlsson SV, Catalona WJ, Dahl DM, Dall'Era M, Davis JW, Drake BF, Epstein JI, Etzioni RB, Farrington TA, Garraway IP, Jarrard D, Kauffman E, Kaye D, Kibel AS, LaGrange CA, Maroni P, Ponsky L, Reys B, Salami SS, Sanchez A, Seibert TM, Shaneyfelt TM, Smaldone MC, Sonn G, Tyson MD, Vapiwala N, Wake R, Washington S, Yu A, Yuh B, Berardi RA, Freedman-Cass DA. PMID: 36898362.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    9. Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention. Eur Urol. 2023 03; 83(3):241-248. Seibert TM, Garraway IP, Plym A, Mahal BA, Giri V, Jacobs MF, Cheng HH, Loeb S, Helfand BT, Eeles RA, Morgan TM. PMID: 36609003.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    10. Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes. Cancer. 2023 01 01; 129(1):82-88. Riviere P, Kalavacherla S, Banegas MP, Javier-Desloges J, Martinez ME, Garraway IP, Murphy JD, Rose BS. PMID: 36345568.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    11. For us by us: Instituting mentorship models that credit minoritized medical faculty expertise and lived experience. Front Med (Lausanne). 2022; 9:966193. Bath EP, Brown K, Harris C, Guerrero A, Kozman D, Flippen CC, Garraway I, Watson K, Holly L, Godoy SM, Norris K, Wyatt G. PMID: 36341236; PMCID: PMC9634999.
      View in: PubMed   Mentions: 1  
    12. The distinct impacts of race and genetic ancestry on health. Nat Med. 2022 05; 28(5):890-893. Rebbeck TR, Mahal B, Maxwell KN, Garraway IP, Yamoah K. PMID: 35534567.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    13. Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer. J Natl Cancer Inst. 2022 04 11; 114(4):592-599. Qiao EM, Lynch JA, Lee KM, Kotha NV, Nalawade V, Voora RS, Qian AS, Nelson TJ, Yamoah K, Garraway IP, Stewart TF, Parsons JK, Rose BS. PMID: 34893859; PMCID: PMC9002290.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource. Cancer Epidemiol Biomarkers Prev. 2022 04 01; 31(4):715-727. Ouellet V, Erickson A, GAP1 UTMAs Contributing Investigators, Wiley K, Morrissey C, Berge V, Moreno CS, Tasken KA, Trudel D, True LD, Lewis MS, Svindland A, Ertunc O, Vidal ID, Osunkoya AO, Jones T, Bova GS, Lamminen T, Achtman AH, Buzza M, Kouspou MM, Bigler SA, Zhou X, Freedland SJ, Mes-Masson AM, Garraway IP, Trock BJ, Taimen P, Saad F, Mirtti T, Knudsen BS, De Marzo AM. PMID: 35131885; PMCID: PMC9381093.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System. JAMA Netw Open. 2022 01 04; 5(1):e2144027. Yamoah K, Lee KM, Awasthi S, Alba PR, Perez C, Anglin-Foote TR, Robison B, Gao A, DuVall SL, Katsoulakis E, Wong YN, Markt SC, Rose BS, Burri R, Wang C, Aboiralor O, Fink AK, Nickols NG, Lynch JA, Garraway IP. PMID: 35040965; PMCID: PMC8767437.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    16. Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis. JAMA Netw Open. 2021 12 01; 4(12):e2139769. Ma TM, Romero T, Nickols NG, Rettig MB, Garraway IP, Roach M, Michalski JM, Pisansky TM, Lee WR, Jones CU, Rosenthal SA, Wang C, Hartman H, Nguyen PL, Feng FY, Boutros PC, Saigal C, Chamie K, Jackson WC, Morgan TM, Mehra R, Salami SS, Vince R, Schaeffer EM, Mahal BA, Dess RT, Steinberg ML, Elashoff D, Sandler HM, Spratt DE, Kishan AU. PMID: 34964855; PMCID: PMC8717118.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    17. The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation. Int J Radiat Oncol Biol Phys. 2022 05 01; 113(1):66-76. Tward J, Lenz L, Flake DD, Rajamani S, Yonover P, Olsson C, Kapoor DA, Mantz C, Liauw SL, Antic T, Fabrizio M, Salzstein D, Shore N, Albertson D, Henderson J, Lee SP, Gay HA, Michalski J, Hung A, Raben D, Garraway I, Lewis MS, Nguyen PL, Marshall DT, Brawer MK, Stone S, Cohen T. PMID: 34610388.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men. J Natl Cancer Inst. 2021 10 01; 113(10):1343-1351. Klebaner D, Courtney PT, Garraway IP, Einck J, Kumar A, Martinez ME, McKay R, Murphy JD, Parada H, Sandhu A, Stewart T, Yamoah K, Rose BS. PMID: 33892497; PMCID: PMC8486332.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    19. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration. Cancer. 2021 02 01; 127(3):403-411. McKay RR, Sarkar RR, Kumar A, Einck JP, Garraway IP, Lynch JA, Mundt AJ, Murphy JD, Stewart TF, Yamoah K, Rose BS. PMID: 33036065.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    20. The Impact of 18F-DCFPyL PET-CT Imaging on Initial Staging, Radiation, and Systemic Therapy Treatment Recommendations for Veterans With Aggressive Prostate Cancer. Adv Radiat Oncol. 2020 Nov-Dec; 5(6):1364-1369. Parikh NR, Tsai S, Bennett C, Lewis M, Sadeghi A, Lorentz W, Cheung M, Garraway I, Aronson W, Kishan AU, Bahri S, Vahidi K, Calais J, Ishimitsu D, Rettig M, Nickols NG, Jafari L. PMID: 33305100; PMCID: PMC7718503.
      View in: PubMed   Mentions:
    21. Prostate cancer reactivates developmental epigenomic programs during metastatic progression. Nat Genet. 2020 08; 52(8):790-799. Pomerantz MM, Qiu X, Zhu Y, Takeda DY, Pan W, Baca SC, Gusev A, Korthauer KD, Severson TM, Ha G, Viswanathan SR, Seo JH, Nguyen HM, Zhang B, Pasaniuc B, Giambartolomei C, Alaiwi SA, Bell CA, O'Connor EP, Chabot MS, Stillman DR, Lis R, Font-Tello A, Li L, Cejas P, Bergman AM, Sanders J, van der Poel HG, Gayther SA, Lawrenson K, Fonseca MAS, Reddy J, Corona RI, Martovetsky G, Egan B, Choueiri T, Ellis L, Garraway IP, Lee GM, Corey E, Long HW, Zwart W, Freedman ML. PMID: 32690948; PMCID: PMC10007911.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCells
    22. The Role of Opioids and Their Receptors in Urological Malignancy: A Review. J Urol. 2020 Dec; 204(6):1150-1159. Lec PM, Lenis AT, Golla V, Brisbane W, Shuch B, Garraway IP, Reiter RE, Chamie K. PMID: 32516030.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    23. Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer. Eur Urol. 2020 09; 78(3):327-332. Kishan AU, Romero T, Alshalalfa M, Liu Y, Tran PT, Nickols NG, Ye H, Sajed D, Rettig MB, Reiter RE, Garraway IP, Spratt DE, Freedland SJ, Zhao X, Li Z, Deek M, Livingstone J, Mahal BA, Nguyen PL, Feng FY, Den RB, Schaeffer EM, Lotan TL, Karnes RJ, Klein EA, Ross AE, Grogan T, Davicioni E, Elashoff D, Boutros PC, Weidhaas JB. PMID: 32461072; PMCID: PMC8954568.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    24. Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential. BMC Cancer. 2020 May 07; 20(1):398. Miller ET, You S, Cadaneanu RM, Kim M, Yoon J, Liu ST, Li X, Kwan L, Hodge J, Quist MJ, Grasso CS, Lewis MS, Knudsen BS, Freeman MR, Garraway IP. PMID: 32380981; PMCID: PMC7204307.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    25. Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression. Cancer Res. 2019 07 15; 79(14):3636-3650. Hughes RM, Simons BW, Khan H, Miller R, Kugler V, Torquato S, Theodros D, Haffner MC, Lotan T, Huang J, Davicioni E, An SS, Riddle RC, Thorek DLJ, Garraway IP, Fertig EJ, Isaacs JT, Brennen WN, Park BH, Hurley PJ. PMID: 31123087; PMCID: PMC6734938.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    26. A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer. Theranostics. 2019; 9(10):2812-2826. Jan YJ, Yoon J, Chen JF, Teng PC, Yao N, Cheng S, Lozano A, Chu GCY, Chung H, Lu YT, Chen PJ, Wang JJ, Lee YT, Kim M, Zhu Y, Knudsen BS, Feng FY, Garraway IP, Gao AC, Chung LWK, Freeman MR, You S, Tseng HR, Posadas EM. PMID: 31244925; PMCID: PMC6568173.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    27. Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease. BMC Cancer. 2019 Apr 01; 19(1):291. Parikh NR, Huiza C, Patel JS, Tsai S, Kalpage N, Thein M, Pitcher S, Lee SP, Inouye WS, Jordan ML, Sanati H, Jafari L, Bennett CJ, Gin GE, Kishan AU, Reiter RE, Lewis M, Sadeghi A, Aronson WJ, Garraway IP, Rettig MB, Nickols NG. PMID: 30935383; PMCID: PMC6444674.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    28. ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. Nat Med. 2018 12; 24(12):1887-1898. Rotinen M, You S, Yang J, Coetzee SG, Reis-Sobreiro M, Huang WC, Huang F, Pan X, Yáñez A, Hazelett DJ, Chu CY, Steadman K, Morrissey CM, Nelson PS, Corey E, Chung LWK, Freedland SJ, Di Vizio D, Garraway IP, Murali R, Knudsen BS, Freeman MR. PMID: 30478421; PMCID: PMC6614557.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansAnimalsCells
    29. Clonal diversity revealed by morphoproteomic and copy number profiles of single prostate cancer cells at diagnosis. Converg Sci Phys Oncol. 2018 Mar; 4(1). Malihi PD, Morikado M, Welter L, Liu ST, Miller ET, Cadaneanu RM, Knudsen BS, Lewis MS, Carlsson A, Velasco CR, Kolatkar A, Rodriguez-Lee M, Garraway IP, Hicks J, Kuhn P. PMID: 32670616; PMCID: PMC7363158.
      View in: PubMed   Mentions: 19  
    30. Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate. Oncotarget. 2017 Jul 18; 8(29):46710-46727. Brennen WN, Zhang B, Kulac I, Kisteman LN, Antony L, Wang H, Meeker AK, De Marzo AM, Garraway IP, Denmeade SR, Isaacs JT. PMID: 28493842; PMCID: PMC5564518.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    31. Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer. Cancer Med. 2017 01; 6(1):163-172. Miller ET, Chamie K, Kwan L, Lewis MS, Knudsen BS, Garraway IP. PMID: 27997745; PMCID: PMC5269571.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    32. Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells. Oncotarget. 2016 Dec 20; 7(51):84645-84657. Li Q, Yin L, Jones LW, Chu GC, Wu JB, Huang JM, Li Q, You S, Kim J, Lu YT, Mrdenovic S, Wang R, Freeman MR, Garraway I, Lewis MS, Chung LW, Zhau HE. PMID: 27835867; PMCID: PMC5356688.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    33. Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone. PLoS One. 2016; 11(10):e0163232. Liu S, Cadaneanu RM, Zhang B, Huo L, Lai K, Li X, Galet C, Grogan TR, Elashoff D, Freedland SJ, Rettig M, Aronson WJ, Knudsen BS, Lewis MS, Garraway IP. PMID: 27711225; PMCID: PMC5053503.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    34. Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome. Cancer Res. 2016 09 01; 76(17):4948-58. You S, Knudsen BS, Erho N, Alshalalfa M, Takhar M, Al-Deen Ashab H, Davicioni E, Karnes RJ, Klein EA, Den RB, Ross AE, Schaeffer EM, Garraway IP, Kim J, Freeman MR. PMID: 27302169; PMCID: PMC5047668.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCells
    35. Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting. Prostate. 2016 Feb; 76(2):125-39. Miyahira AK, Lang JM, Den RB, Garraway IP, Lotan TL, Ross AE, Stoyanova T, Cho SY, Simons JW, Pienta KJ, Soule HR. PMID: 26477609; PMCID: PMC5830186.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    36. YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer. Nat Commun. 2015 Sep 01; 6:8126. Kuser-Abali G, Alptekin A, Lewis M, Garraway IP, Cinar B. PMID: 28230103; PMCID: PMC5327734.
      View in: PubMed   Mentions: 55     Fields:    
    37. Differential gene expression profiling of functionally and developmentally distinct human prostate epithelial populations. Prostate. 2015 May; 75(7):764-76. Liu H, Cadaneanu RM, Lai K, Zhang B, Huo L, An DS, Li X, Lewis MS, Garraway IP. PMID: 25663004; PMCID: PMC4409819.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    38. Targeting the RANKL pathway: putting the brakes on prostate cancer progression in bone. J Clin Oncol. 2013 Oct 20; 31(30):3838-40. Garraway IP. PMID: 24043735.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    39. Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model. Am J Cancer Res. 2012; 2(6):745-51. Peek EM, Li DR, Zhang H, Kim HP, Zhang B, Garraway IP, Chin AI. PMID: 23226620; PMCID: PMC3512189.
      View in: PubMed   Mentions: 7  
    40. Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer. J Biol Chem. 2012 Nov 02; 287(45):37732-44. Hance MW, Dole K, Gopal U, Bohonowych JE, Jezierska-Drutel A, Neumann CA, Liu H, Garraway IP, Isaacs JS. PMID: 22989880; PMCID: PMC3488049.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCells
    41. Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells. PLoS One. 2012; 7(8):e42564. Jiao J, Hindoyan A, Wang S, Tran LM, Goldstein AS, Lawson D, Chen D, Li Y, Guo C, Zhang B, Fazli L, Gleave M, Witte ON, Garraway IP, Wu H. PMID: 22880034; PMCID: PMC3411798.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansAnimalsCells
    42. Will identification of a prostate cancer stem cell lead to its cure? Urol Oncol. 2012 Jul-Aug; 30(4):351-2. Garraway IP. PMID: 22930822.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    43. Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability. PLoS One. 2012; 7(4):e34219. Guo C, Liu H, Zhang BH, Cadaneanu RM, Mayle AM, Garraway IP. PMID: 22514625; PMCID: PMC3326009.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    44. Isolation and characterization of human prostate stem/progenitor cells. Methods Mol Biol. 2012; 879:315-26. Guo C, Zhang B, Garraway IP. PMID: 22610567.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    45. Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. Cancer Cell. 2011 Jun 14; 19(6):792-804. Mulholland DJ, Tran LM, Li Y, Cai H, Morim A, Wang S, Plaisier S, Garraway IP, Huang J, Graeber TG, Wu H. PMID: 21620777; PMCID: PMC3157296.
      View in: PubMed   Mentions: 298     Fields:    Translation:HumansAnimalsCells
    46. Identification of a cell of origin for human prostate cancer. Science. 2010 Jul 30; 329(5991):568-71. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. PMID: 20671189; PMCID: PMC2917982.
      View in: PubMed   Mentions: 325     Fields:    Translation:HumansAnimalsCells
    47. Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. J Urol. 2010 Jun; 183(6):2403-8. Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Garraway I, Wong SG, Belldegrun AS, Pantuck AJ. PMID: 20403620.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    48. Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate. 2010 Apr 01; 70(5):491-501. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS, Hahm SA, Haider M, Head CS, Reiter RE, Rubin MA, Witte ON. PMID: 19938015; PMCID: PMC2885946.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCells
    49. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A. 2008 Dec 30; 105(52):20882-7. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON. PMID: 19088204; PMCID: PMC2603432.
      View in: PubMed   Mentions: 201     Fields:    Translation:HumansAnimalsCells
    50. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines. Urol Oncol. 2010 Mar-Apr; 28(2):180-8. Wallerand H, Cai Y, Wainberg ZA, Garraway I, Lascombe I, Nicolle G, Thiery JP, Bittard H, Radvanyi F, Reiter RR. PMID: 19070520.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    51. Epithelial stem cells of the prostate and their role in cancer progression. Cold Spring Harb Symp Quant Biol. 2008; 73:491-502. Lukacs RU, Lawson DA, Xin L, Zong Y, Garraway I, Goldstein AS, Memarzadeh S, Witte ON. PMID: 19022743.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    52. Trefoil factor 3 is overexpressed in human prostate cancer. Prostate. 2004 Nov 01; 61(3):209-14. Garraway IP, Seligson D, Said J, Horvath S, Reiter RE. PMID: 15368472.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    53. Current treatment options for penile fractures. Rev Urol. 2004; 6(3):114-20. Jack GS, Garraway I, Reznichek R, Rajfer J. PMID: 16985591; PMCID: PMC1472832.
      View in: PubMed   Mentions: 26  
    54. Case scenario: 26-year-old male with right scrotal pain and swelling. Rev Urol. 2002; 4(1):43. Garraway I, Liao J, Rajfer J. PMID: 16985652; PMCID: PMC1475959.
      View in: PubMed   Mentions:
    55. Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev. 2001 Jul 15; 15(14):1817-32. Trinh LA, Ferrini R, Cobb BS, Weinmann AS, Hahm K, Ernst P, Garraway IP, Merkenschlager M, Smale ST. PMID: 11459831; PMCID: PMC312741.
      View in: PubMed   Mentions: 37     Fields:    Translation:Cells
    56. Transcription of the lymphocyte-specific terminal deoxynucleotidyltransferase gene requires a specific core promoter structure. Proc Natl Acad Sci U S A. 1996 Apr 30; 93(9):4336-41. Garraway IP, Semple K, Smale ST. PMID: 8633066; PMCID: PMC39537.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    Isla's Networks
    Concepts (246)
    Derived automatically from this person's publications.
    _
    Co-Authors (71)
    People in Profiles who have published with this person.
    _
    Similar People (59)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _